These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21917961)

  • 1. Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.
    Orlova N; Wang F; Fogg MH
    J Virol; 2011 Dec; 85(23):12821-4. PubMed ID: 21917961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.
    Orlova N; Fogg MH; Carville A; Wang F
    Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.
    Leskowitz RM; Zhou XY; Villinger F; Fogg MH; Kaur A; Lieberman PM; Wang F; Ertl HC
    J Virol; 2013 Aug; 87(15):8351-62. PubMed ID: 23698300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
    Fogg MH; Garry D; Awad A; Wang F; Kaur A
    J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
    Fogg MH; Kaur A; Cho YG; Wang F
    J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.
    Sashihara J; Hoshino Y; Bowman JJ; Krogmann T; Burbelo PD; Coffield VM; Kamrud K; Cohen JI
    PLoS Pathog; 2011 Oct; 7(10):e1002308. PubMed ID: 22028652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new animal model for Epstein-Barr virus pathogenesis.
    Wang F
    Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863
    [No Abstract]   [Full Text] [Related]  

  • 8. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.
    Ohashi M; Fogg MH; Orlova N; Quink C; Wang F
    PLoS Pathog; 2012 Dec; 8(12):e1003095. PubMed ID: 23300447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.
    Leskowitz R; Fogg MH; Zhou XY; Kaur A; Silveira EL; Villinger F; Lieberman PM; Wang F; Ertl HC
    J Virol; 2014 May; 88(9):4721-35. PubMed ID: 24522914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.
    Ohashi M; Orlova N; Quink C; Wang F
    J Virol; 2011 Feb; 85(3):1330-9. PubMed ID: 21084476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
    Herrman M; Mühe J; Quink C; Wang F
    J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.
    Edwards KR; Schmidt K; Homad LJ; Kher GM; Xu G; Rodrigues KA; Ben-Akiva E; Abbott J; Prlic M; Newell EW; De Rosa SC; Irvine DJ; Pancera M; McGuire AT
    Cell Rep Med; 2024 Jun; 5(6):101587. PubMed ID: 38781964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.
    Croft NP; Shannon-Lowe C; Bell AI; Horst D; Kremmer E; Ressing ME; Wiertz EJ; Middeldorp JM; Rowe M; Rickinson AB; Hislop AD
    PLoS Pathog; 2009 Jun; 5(6):e1000490. PubMed ID: 19557156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-human Primate Lymphocryptoviruses: Past, Present, and Future.
    Mühe J; Wang F
    Curr Top Microbiol Immunol; 2015; 391():385-405. PubMed ID: 26428382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.
    Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F
    J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell immunity to Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.
    Hislop AD; Sabbah S
    Semin Cancer Biol; 2008 Dec; 18(6):416-22. PubMed ID: 19007888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.
    Quinn LL; Zuo J; Abbott RJ; Shannon-Lowe C; Tierney RJ; Hislop AD; Rowe M
    PLoS Pathog; 2014 Aug; 10(8):e1004322. PubMed ID: 25144360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.
    Rivailler P; Carville A; Kaur A; Rao P; Quink C; Kutok JL; Westmoreland S; Klumpp S; Simon M; Aster JC; Wang F
    Blood; 2004 Sep; 104(5):1482-9. PubMed ID: 15150077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.